Genetic Polymorphism and Tumor Immunotherapy
Journal:
Current Pharmacogenomics
Volume:
1
Page:
37-57
Author(s):
Rongcun Yang and Richard B.S. Roden
Cardiac Toxicity of Antineoplastic Anthracyclines
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
151-171
Author(s):
Riccardo Zucchi and Romano Danesi
Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
2
Page:
67-79
Author(s):
Cinzia Bizzarri, Marcello Allegretti, Rosa Di Bitondo, Maria Neve Cervellera, Francesco Colotta and Riccardo Bertini
Recombinant Secretory Immunoglobulin A in Passive Immunotherapy: Linking Immunology and Biotechnology
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
51-67
Author(s):
Blaise Corthésy
Selecting the Components for a Safe and Efficient Tuberculosis Subunit Vaccine - Recent Progress and Post-Genomic Insights
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
69-83
Author(s):
Limei Meng Okkels, T. Mark Doherty and Peter Andersen
Probiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
175-191
Author(s):
A. Mercenier, S. Pavan and B. Pot
Cancer Chemoprevention Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
45-54
Author(s):
K. Krishnan, S. Campbell, F. Abdel-Rahman, S. Whaley and W. L. Stone
Membrane Receptors for Vitamin D Steroid Hormones: Potential NewDrug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
67-76
Author(s):
M. C. Farach-Carson and I. Nemere
Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
305-320
Author(s):
Meng Ling-hua, Liao Zhi-yong and Yves Pommier
Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
339-353
Author(s):
William A. Denny and Bruce C. Baguley